Alkermes plc. Amortization of Debt Issuance Costs and Discounts
Alkermes plc. (ALKS) reported Amortization of Debt Issuance Costs and Discounts of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-07-28
- Alkermes plc. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $800.00K.
- Alkermes plc. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $400.00K.
- Alkermes plc. amortization of debt issuance costs and discounts for the quarter ending 2013-03-31 was $300.00K, a 78.57% decline year-over-year.
- Alkermes plc. amortization of debt issuance costs and discounts for the quarter ending 2012-12-31 was $2.50M, a 38.89% increase year-over-year.
- Alkermes plc. amortization of debt issuance costs and discounts for fiscal 2022 was $500.00K, a 0.00% change from fiscal 2021.
- Alkermes plc. amortization of debt issuance costs and discounts for fiscal 2021 was $500.00K, a 28.57% decline from fiscal 2020.
- Alkermes plc. amortization of debt issuance costs and discounts for fiscal 2020 was $700.00K, a 0.00% change from fiscal 2019.
- Alkermes plc. amortization of debt issuance costs and discounts for fiscal 2019 was $700.00K, a 0.00% change from fiscal 2018.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-07-28 | $1.20M 10-Q · filed 2026-07-28 | ||
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-05 | |||
| 2022-12-31 | $500.00K 10-K · filed 2023-02-16 | |||
| 2021-12-31 | $500.00K 10-K · filed 2023-02-16 | |||
| 2020-12-31 | $700.00K 10-K · filed 2023-02-16 | |||
| 2019-12-31 | $700.00K 10-K · filed 2022-02-16 | |||
| 2018-12-31 | $700.00K 10-K · filed 2021-02-11 | |||
| 2017-12-31 | $800.00K 10-K · filed 2020-02-13 | |||
| 2016-12-31 | $900.00K 10-K · filed 2019-02-15 | |||
| 2015-12-31 | $900.00K 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $1.00M 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $800.00K 10-K · filed 2016-02-25 | |||
| 2013-03-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $2.80M derived: sum of 2 quarters · filed 2015-02-24 | $5.80M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $5.50M 10-Q · filed 2013-01-31 | ||
| 2012-09-30 | $3.00M 10-Q · filed 2012-11-01 | |||
| 2012-03-31 | $1.40M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $3.20M derived: sum of 2 quarters · filed 2014-02-27 | $3.50M 10-KT · filed 2014-02-27 | |
| 2011-12-31 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $2.10M 10-Q · filed 2013-01-31 | ||
| 2011-09-30 | $300.00K 10-Q · filed 2012-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |